Relevance of osteoproliferation as an outcome parameter in ankylosing spondylitis

被引：0
|
作者：
Heiner Appel
Martin Rudwaleit
Joachim Sieper
机构：
[1] Germany.,H Appel and M Rudwaleit are both Consultants and Lecturers in the Department of Medicine at the Charité Hospital Benjamin Franklin and J Sieper is Head of Rheumatology at the Campus Benjamin Franklin of the Charité University Hospital in Berlin
来源：
Nature Clinical Practice Rheumatology | 2008年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In light of the impressive efficacy of tumor necrosis factor blockers in the treatment of ankylosing spondylitis, particularly in patients with short disease duration, defining outcome parameters to monitor the structural damage of the disease has become more pertinent. In this Viewpoint the authors explore the relevance of osteoproliferation amongst other outcome parameters.
引用
收藏
页码：578 / 579
页数：1
相关论文
共 50 条
  • [1] Relevance of osteoproliferation as an outcome parameter in ankylosing spondylitis
    Appel, Heiner
    Rudwaleit, Martin
    Sieper, Joachim
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (11): : 578 - 579
  • [2] Biomarkers of Bone Metabolism in Ankylosing Spondylitis in Relation to Osteoproliferation and Osteoporosis
    Klingberg, Eva
    Nurkkala, Merja
    Carlsten, Hans
    Forsblad-d'Elia, Helena
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1349 - 1356
  • [3] Outcome parameters in ankylosing spondylitis [Outcome-parameter bei der ankylosierenden spondylitis]
    Haibel H.
    Rudwaleit M.
    Sieper J.
    Zeitschrift für Rheumatologie, 2006, 65 (2) : 131 - 138
  • [4] Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis
    L. Torres
    E. Klingberg
    M. Nurkkala
    H. Carlsten
    H. Forsblad-d’Elia
    Osteoporosis International, 2019, 30 : 441 - 449
  • [5] What is the most important outcome parameter in ankylosing spondylitis
    Braun, J.
    Sieper, J.
    RHEUMATOLOGY, 2008, 47 (12) : 1738 - 1740
  • [6] Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis
    Torres, L.
    Klingberg, E.
    Nurkkala, M.
    Carlsten, H.
    Forsblad-d'Elia, H.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (02) : 441 - 449
  • [7] Outcome variables in ankylosing spondylitis: Evaluation of their relevance and discriminant capacity
    Calin, A
    Nakache, JP
    Gueguen, A
    Zeidler, H
    Mielants, H
    Dougados, M
    JOURNAL OF RHEUMATOLOGY, 1999, 26 (04) : 975 - 979
  • [8] Outcome parameters in ankylosing spondylitis
    Haibel, H
    Rudwaleit, M
    Sieper, J
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2006, 65 (02): : 131 - +
  • [9] Smoking and outcome in ankylosing spondylitis
    Averns, HL
    Oxtoby, J
    Taylor, HG
    Jones, PW
    Dziedzic, K
    Dawes, PT
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1996, 25 (03) : 138 - 142
  • [10] Predicting outcome in ankylosing spondylitis
    Pradeep, D. J.
    Keat, A.
    Gaffney, K.
    RHEUMATOLOGY, 2008, 47 (07) : 942 - 945
12345